QNTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Quantum Biopharma Ltd (QNTM) is not a strong buy at this moment for a beginner investor with a long-term strategy. The company's financial performance is weak, with declining net income and EPS, and there are no positive trading signals or catalysts to support an immediate investment. Additionally, the pre-market price drop and lack of significant trading trends or news further suggest a cautious approach.
The MACD is positive but contracting, RSI is neutral at 59.925, and moving averages are converging, indicating no strong trend. Key support is at 2.293, and resistance is at 4.944. The stock has a 70% chance of minor losses in the short term (-1.91% next day, -1.36% next week) but a slight recovery (+2.03%) in the next month.
NULL identified. No recent news or significant trading activity from hedge funds, insiders, or Congress.
Pre-market price drop of -5.22%, weak financial performance in the latest quarter, and no significant trading trends or news.
In Q4 2025, revenue remained at 0 with no growth, net income dropped by -36.20% YoY to -3,026,467, and EPS fell by -66.95% YoY to -0.79. Gross margin also remained at 0 with no growth.
No analyst rating or price target data available.
